Adult T-cell leukemia/lymphoma (ATL) develops in human T-cell leukemia virus type 1 (HTLV-1) carriers. Although the HTLV-1-encoded HBZ gene is critically involved, HBZ alone is insufficient and additional, cooperative "hits" are required for the development of ATL. Candidate cooperative hits are being defined, but methods to rapidly explore their roles in ATL development in collaboration with HBZ are lacking. Here, we present a new mouse model of acute type ATL that can be generated rapidly by transplanting in vitro-induced T cells that have been retrovirally transduced with HBZ and two cooperative genes, BCLxL and AKT, into mice. Co-transduction of HBZ and BCLxL/AKT allowed these T cells to grow in vitro in the absence of cytokines (Flt3-ligand and interleukin-7), which did not occur with any two-gene combination. Although transplanted T cells were a mixture of cells transduced with different combinations of the genes, tumors that developed in mice were composed of HBZ/BCLxL/AKT triply transduced T cells, showing the synergistic effect of the three genes. The genetic/epigenetic landscape of ATL has only recently been elucidated, and the roles of additional "hits" in ATL pathogenesis remain to be explored. Our model provides a versatile tool to examine the roles of these hits, in collaboration with HBZ, in the development of acute ATL.
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A dult T-cell leukemia/lymphoma (ATL) is a T-cell neoplasm with poor clinical outcomes. It develops in roughly 5% of human T-cell leukemia virus type 1 (HTLV-1) carriers at an advanced age.
(1,2) Such a low penetrance and long latency period suggest that, in addition to HTLV-1 infection, the accumulation of cooperative genetic or epigenetic "hits" is required for the development of ATL. Among HTLV-1 genes, Tax and HTLV bZip factor (HBZ) are regarded as central to the development of ATL. However, although Tax has potent oncogenic activity, it is often undetectable in advanced ATL. In contrast, HBZ is expressed in all cases, suggesting a critical role for this gene in the development of ATL. (3) To elucidate the molecular mechanisms underlying ATL development, several mouse models, including Tax-transgenic mice and HTLV-1-infected humanized mice, have been developed; however, these models are not suitable for analyzing the roles of HBZ in ATL. (4, 5) HBZ-transgenic mice are unique in that they develop ATL-like disease, (6) although the disease develops only after a prolonged latency period and with low penetrance, again suggesting the requirement of cooperative "hits."
To study candidate cooperative genes and their involvement in the development of ATL, models generated by crossing genetically modified mice with HBZ-transgenic mice are required; however, this approach is laborious and timeconsuming. Therefore, a new mouse model of ATL would facilitate the study of molecular mechanisms underlying the development of ATL.
We have developed a method to rapidly generate mouse models of T-cell neoplasms by transplanting in vitro-generated, gene-transduced T cells. (7) We used this method to examine the cooperation of HBZ with Akt and BCLxL and the effect of Ink4a/Arf loss in the development of acute ATL.
Materials and Methods
Induction of T cells in vitro, transduction of retroviral genes, and transplantation. Ink4a/Arf-null mice (B6.129-Cdkn2a tm1Rdp /Nci) were obtained from the National Cancer Institute (Frederick, MD, USA). Fetal liver cells isolated from Ink4a/Arf-null mice (14 days post-coitum) were depleted of Ter119-positive cells and cocultured with an X-irradiated (15 Gy) OP9-DL1 stromal cell (RIKEN BRC, Tsukuba, Japan) layer in a 6-well culture plate in Iscove's modified Dulbecco's medium (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% FCS, in the presence of mouse FMS-like tyrosine kinase 3 (Flt3)-ligand (5 ng/mL; PeproTech, Rocky Hill, NJ, USA) and 0.5% culture supernatant from the mouse interleukin-7 (IL7)-producing cell line J558L-IL7 (provided by Dr. A.G. Rolink, University of Basel, Basel, Switzerland), as previously described. (7) Cells were harvested and seeded at 5 9 10 4 cells/well onto a fresh OP9-DL1 layer every 7 days (Fig. 1a) . Cells were infected with retrovirus on day 15 and transplanted (5-10 9 10 6 cells/well) i.v. into irradiated (2.5 Gy) NSG mice (NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ; Jackson Laboratory, Bar Harbor, ME, USA) or irradiated (15 Gy) C57BL6 mice (Charles River, Atsugi, Japan) 28 days after initiation of the culture, together with 1 9 10 6 fresh bone marrow cells for radioprotection. A total of 5-10 9 10 6 cells obtained from the thymuses, spleens, or tumors of primary recipient mice were used for secondary transplantations. All animal experiments were carried out according to protocols approved by the Institutional Animal Care and Use Committee at the Aichi Cancer Center (Nagoya, Japan).
Cell growth assay. In vitro-induced T cells were grown on an OP9-DL1 stromal cell layer for 7 days after gene transduction and then subjected to a growth assay. Cells were seeded at a density of 1 9 10 5 cells/well in a 6-well culture plate in which OP9-DL1 cells had been cultured to confluency and irradiated (15 Gy), and were cultured in Iscove's modified Dulbecco's medium supplemented with 10% FCS in the presence or absence of cytokines (5 ng/mL Flt3 ligand and 0.5% culture supernatant of IL-7-producing cell line J558L-IL7). Cells cultured in triplicate were then counted 7 and 14 days after the initiation of culture.
Retroviral plasmids. cDNA of the HBZ gene and 35 bp of the 5 0 -non-coding region was amplified by nested PCR using an HTLV-1 plasmid (a kind gift of Dr. N. Ishida, Tokyo University, Tokyo, Japan) as a template and inserted into the NotI/XhoI site of a pSIN-PGK-IRES-human (h)CD8 plasmid (constructed by inserting a PGK-IRES-hCD8 cassette into a pSIN vector purchased from Takara Bio, Kusatsu, Japan). Primer sets used were as follows:
0 . The cDNA for myristoylated Akt (7) was used to express active Akt along with GFP in an MSCV retrovirus vector. The cDNA for BCLxL, kindly provided by Dr. Nunez G, University of Chicago, IL, USA (8) was inserted into the EcoRI site of the MSCV-IRES-hCD4 vector. Flow cytometric analysis and cell sorting. Biotinylated antibodies against hCD8 (HIT8a) and mouse CD4 (GK1.5) in conjunction with streptavidin-allophycocyanin and phycoerythrinconjugated anti-hCD4 (RPA-T4) and anti-mouse CD8 (53-6.7) antibodies (all from eBioscience, San Diego, CA, USA) were used. Flow cytometry was carried out using a FACSCalibur instrument (BD Biosciences, Franklin Lakes, NJ, USA) and FlowJo software version 7.6.5 (Tree Star, Ashland, OR, USA).
Western blot analysis. Rabbit mAb for mouse and human BCLxL (54H6 #2764), rabbit mAb for mouse, rat, and human Akt (C67E7 #4691), rabbit polyclonal antibody for mouse, rat, and human phospho-Akt (Ser473)(#9271), rabbit mAb for mouse and human glycogen synthase kinase (Gsk)3b (27C10 #9315), rabbit mAb for mouse and human phospho-Gsk3b (Ser9 5B3 #9323), rabbit mAb for mouse and human p70 S6 kinase (49D7 #2708), rabbit mAb for mouse and human phospho-p70 S6 kinase (108D2 #9234) (all from Cell Signaling Technology, Danvers, MA, USA), rabbit polyclonal antibody against a myc tag (A14; from Santa Cruz Biotechnology, Dallas, TX, USA), and mouse mAb reactive to mouse and human a-tubulin (DM1A #T9026; Sigma-Aldrich, St. Louis, MO, USA) were used.
Analysis of clonality of cells. Clonality was assessed by PCR amplification of the T-cell receptor b gene (Db2-Jb fragment), as described previously. (7) Statistical analyses. Statistical analyses were carried out using EZR software. (9) Results HBZ facilitates cytokine-independent growth of Akt/BCLxLtransduced T cells in vitro. We searched for genes and other factors that might function in cooperation with HBZ, and chose Akt and the loss of Ink4a/Arf for further evaluation. Akt is activated in most ATL cells, in part due to epigenetic silencing of NDRG2 (10) and mutations in CCR4. (11) Ink4a/Arf is often lost in acute ATL, and this loss is associated with disease progression. (12, 13) T cells were induced from fetal liver cells of Ink4a/ Arf-null mice on OP9-DL1 stromal cells in the presence of cytokines (Flt3-ligand and IL-7). Flow cytometric analysis of cells in culture (Fig. S1a) (Fig. 1a, left panel) . Our initial attempt to confer a growth advantage to Ink4a/Arf-null T cells by expressing HBZ and Akt was unsuccessful. In the presence of cytokines (FL and IL-7), the cells grew comparably with control cells. In the absence of cytokines, the cell number declined over time as did that of the control cells, suggesting cell death. We therefore searched for anti-apoptotic genes whose expression was elevated in ATL cells compared with normal T cells. Examination of our gene expression data revealed significantly (P < 0.05) elevated expression of BCLxL among the BCL2 family genes (BCL2, BCLxL, MCL1, BCL-W, and BCL2A1) in acute ATL cells relative to that in normal CD4 T cells (Fig. S2) . (12) Next, therefore, we examined the effects of a combination of HBZ, Akt, and BCLxL, as well as Ink4a/Arf loss, on the growth of T cells in vitro. Retrovirus vectors coexpressed the extracellular domains of human (h)CD8, hCD4, and GFP as surrogate markers for HBZ, BCLxL, and Akt, respectively (Fig. 1a, right panel) , to facilitate the identification of gene(s) transduced in every single cell by flow cytometry. Cells were then cultured on stromal cells and monitored for growth. In the presence of cytokines, the total number of bulk T cells transduced with the three genes (HBZ, Akt, and BCLxL) was not significantly different than those transduced with any combination of two genes (Fig. 1b, left panel) . In contrast, in the absence of cytokines, the total number of bulk T cells transduced with the three genes (HBZ, Akt, and BCLxL) increased over 14 days, whereas the number of T cells transduced with any two of the three genes (Fig. 1b, middle panel) , as well as the vector-only control and uninfected control cells (Fig. S1b) , decreased over time. This suggests cooperation between the three genes in cytokine-independent growth. Flow cytometric analysis showed that, whereas HBZ/Akt/BCLxL triply transduced cells accounted for, at most, approximately 66% of cells in culture on day 0, they accounted for 90% or more on day 7, which is further evidence of cooperation between these three genes (Fig. 1c) . Expression of HBZ, elevated expression of BCLxL, and the presence of activated Akt in cultured T cells were confirmed by Western blotting (Fig. 1d) . Activation of Akt was additionally confirmed by the fact that Gsk3b, a direct target of Akt, was phosphorylated, although phosphorylation of a downstream, indirect target of Akt, p70s6k, was not appreciably augmented (Fig. S3a) . (10, 14) HBZ/Akt/BCLxL triply transduced T cells proliferated more in a Ink4a/Arf À/À than in a Ink4a/Arf +/+ genetic background (Fig. S3b) , and were more viable than HBZ/Akt doubly transduced T cells (Fig. S3d) , although inhibition of caspase 3 cleavage was minimal (Fig. S3c) in the culture conditions used.
Although the combination of HBZ/Akt/BCLxL was required for cytokine-independent growth, loss of Ink4a/Arf seemed dispensable, as the use of Ink4a/Arf-proficient wild-type T cells generated in vitro for the transduction of HBZ, Akt, and BCLxL yielded a similar result to that obtained using Ink4a/Arf-null T cells (Fig. 1b, right panel) .
Development of acute ATL-like disease in mice transplanted with T cells transduced with HBZ, Akt, and BCLxL. Next, we examined tumorigenic activity associated with the combination of HBZ/Akt/BCLxL and Ink4a/Arf-loss in vivo. To this end, Ink4a/Arf-null T cells were transduced with the three genes in vitro, and bulk T cells were transplanted into sublethally irradiated NSG mice. All NSG recipient mice (n = 7) developed leukemia (n = 4) or died (n = 3) within 104 days of transplantation (Fig. 2a, Table 1 ). Although all five mice transplanted with Akt/BCLxL doubly transduced Ink4a/Arf-null bulk T cells died, latency was significantly prolonged compared to that of mice transplanted with HBZ/Akt/BCLxL triply transduced Ink4a/Arf-null T cells (P = 0.0014). NSG mice transplanted with Ink4a/Arf-proficient, HBZ/Akt/BCLxL triply transduced T cells (n = 6) developed leukemia (n = 3) or died (n = 3), with latency comparable to that observed in Ink4a/ Arf-null, HBZ/Akt/BCLxL triply transduced T cells (Fig. 2a) , again suggesting a non-essential role for Ink4a/Arf loss in the development of disease in our experimental conditions (see also Fig. 1b) .
Flow cytometric analysis of cells from a diseased mouse (#4 in Table 1 ) revealed the predominance of HBZ/Akt/BCLxL triply transduced cells in the thymus (>99%) and peripheral blood (~23%), most of which were CD4 + CD8
À cells (80.8% in the thymus and 71.1% in the peripheral blood) (Fig. 2b) . Of particular note, there were atypical lymphocytes with multiply cleaved nuclei that resembled "flower cells" typically seen in acute ATL in humans (Fig. 2c) . (15) The cells infiltrated into various organs, including the lungs and liver (Fig. 2d) . Skin appearance was not evidently affected. The flower cell-like cells were also noted in mice #3 and #5, but not in #7 (Table 1) . CD4 + CD8 À cells were not predominant in mice #3 (Fig. S4) Fig. S5 ). To examine the leukemia-propagating activity of HBZ/Akt/ BCLxL triply transduced T cells in primary recipient mice, submandibular tumor cells obtained from mouse #3 (Table 1) and thymocytes from mouse #4 (Table 1) were transplanted into C57BL6 mice (n = 2 and n = 3, respectively). The secondary recipient mice rapidly succumbed to leukemia within 25 days (Fig. 3a) . Although four mice were found dead, we were able to analyze the single remaining mouse (a recipient of cells from mouse #3), and found that the leukemia cells massively infiltrated various organs, including the bone marrow, thymus, spleen, lungs, and liver ( Fig. 3b-d) . Taken together, these findings reveal the leukemia-propagating activity of HBZ/Akt/BCLxL triply transduced T cells.
The expression of exogenously transduced HBZ, phosphorylated Akt, and BCLxL was evident in tumor cells (Fig. 4a) . Analysis of the clonality of tumors by PCR amplification of the Db2-Jb fragment of the T-cell receptor b revealed the mono-or oligoclonal nature of the tumors (Fig. 4b) , suggesting that a combination of HBZ, Akt, BCLxL, and loss of Ink4a/Arf may not be sufficient, and that additional factors are likely at 
Found dead †Percentages of CD4/CD8 represent those of cells in spleen (Spl) (#1N and #2N) and thymus (Thy) (#4N). ‡Flower cell-like cells were present (+) in Spl (#1N and #2N) and Thy (#4N). BM, bone marrow; Dpt, days post-transplantation; n.d., not done; N.E., not evaluable; PB, peripheral blood. play in tumor development. Elucidation of these factors awaits further investigation.
Although we used NSG mice as the primary recipients, the use of C57BL6 mice yielded a comparable result, but with longer latencies (Fig. S6a) . Although a detailed analysis was precluded by the death of most of the mice, one particular mouse that became moribund on day 64 was found to have flower cell-like cells in the thymus (Fig. S6b) and HBZ/Akt/ BCLxL triply transduced T cells accounted for >80% of cells (Fig. S6c) , again supporting the notion that HBZ, Akt, and BCLxL cooperatively induce ATL-like disease in mice. Another mouse that became moribund on day 30 had HBZ/Akt/ BCLxL triply transduced T cells that comprised 55% of thymocytes, but the cells did not have a flower cell-like appearance (data not shown). HBZ-only transduced T cells did not engraft in C57BL6 recipient mice, as no HBZ + (hCD8 + ) cells were detectable in the peripheral blood, bone marrow, spleen, or thymus following euthanasia on days 34 (n = 1) or 56 (n = 2) (data not shown).
Discussion
Adult T-cell leukemia is an intractable T-cell neoplasm and the only retrovirus-induced cancer known in humans. Although ATL originates in HTLV-1-infected T cells, in which the viral products Tax and HBZ play indispensable roles, ATL cells lack Tax expression whereas HBZ expression is retained, (3, 17) suggesting a central role for HBZ in the development of ATL. Indeed, HBZ-transgenic mice develop ATL-like disease, (6) albeit with low penetrance and only after a long latency period, similar to what is seen in humans. A recent integrated molecular analysis of ATL revealed many genetic mutations and genomic amplifications and deletions. (17) Epigenetic abnormalities were also noted that are likely involved in ATL development. (17, 18) However, the roles of these genetic/epigenetic abnormalities in the development and maintenance of ATL in collaboration with HBZ are not well defined. Our mouse model of ATL allows genes/mutated genes and potentially microRNAs to be easily tested for their roles in ATL development, in collaboration with HBZ. This use for the model was illustrated in the present study to determine collaborations between HBZ, Akt, and BCLxL in the development of ATL-like neoplasms. With our model system, one can test a constellation of candidate genes, using them as a retrovirus "library" for their roles in ATL development in collaboration with HBZ. Although genes/mutated genes found to collaborate with HBZ in tumorigenicity need to be validated for their involvement in ATL through multiple alternative approaches, our model will provide insight into the roles of specific genes/mutated genes in ATL.
Despite our findings in the present study, we do not exclude the possibility that combinations of genes other than HBZ, Akt, and BCLxL are tumorigenic and produce ATL-like disease in mice. However, other combinations of genes we tested (HBZ/ Akt/NIK, HBZ/Akt/Notch1, HBZ/Akt/Ccnd1, and HBZ/Akt/ Ccnd3) were not tumorigenic. NIK expression is elevated in ATL through evasion of miR-31-mediated suppression. (18) Notch1 is activated through mutations in the corresponding gene in some ATL cases. (17, 19) Ccnd1 facilitates the development of Myc/Bcl2-driven T-cell neoplasms in our mouse model. (7) In our preliminary experiments using the above combinations of genes, we found that a combination of HBZ, Akt, and NIK did not provoke cytokine-independent growth of T cells. A combination of Akt and an active Notch1 provoked cytokine-independent growth, and HBZ had no additional effects. Although combinations of HBZ, Akt, and either Ccnd1 or Ccnd3 provoked cytokine-independent growth, the cells did not result in leukemia/lymphoma in transplanted mice; Akt and Ccnd1 or Ccnd3, without HBZ, did not provoke cytokine-independent growth in vitro. Thus, among the combinations of genes we tested, HBZ/Akt/BCLxL was the only one that allowed cytokine-independent growth of T cells in vitro and that was tumorigenic in mice following transplantation. The molecular mechanisms underlying the collaboration between HBZ, Akt, and BCLxL are not clear from the present study, and await further investigation.
Our observation that the presence or absence of the Ink4a/ Arf locus did not affect tumorigenicity of HBZ/Akt/BCLxLtransduced T cells in our mouse model was unexpected, given that the loss of the locus is associated with ATL disease progression. (12, 13) Although the reasons for this inability of Ink4a/ Arf loss to facilitate ATL-like disease in our model are not clear, the loss of Ink4a/Arf locus in humans involves the neighboring DNA elements, such as that encoding hsa-miR-31, the downregulation of which has been implicated in ATL development. (18) In summary, we have established a new method for rapidly generating a mouse model of acute ATL and have shown cooperation between HBZ, Akt, and BCLxL in the development of acute ATL. Thus, our method provides a versatile tool to explore the roles of additional "hits" in cooperation with HBZ in the development of acute ATL.
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